MEDIVATION
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases for which there are limited treatment options. Together with its collaboration partner Astellas Pharma Inc. (Astellas), the Company is developing MDV3100 for multiple stages of advanced prostate cancer. As of December 31, 2011, it completed a Phase III trial in the latest stage. The Company's three subsidiaries include Medivation Prostate Therapeutics, Inc. (MPT), Me... divation Neurology, Inc. (MNI) and Medivation Technologies, Inc. (MTI). MPT holds the Company’s MDV300 series technology, which is in development for the treatment of advanced prostate cancer, and MTI holds its earlier stage technologies. MNI holds its dimebon technology, which was in development for the treatment of Alzheimer’s disease and Huntington disease.
MEDIVATION
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2003-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.medivation.com
Total Employee:
501+
Status:
Active
Contact:
415 5433411
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Domain Not Resolving Google Maps ReCAPTCHA Apple Whitelist Amazon California Region Verizon RagingWire
Similar Organizations
Aerial BioPharma
Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Plough Penny Partners
Plough Penny Partners investment in Post-IPO Equity - Medivation
Official Site Inspections
http://www.medivation.com
- Host name: 172.64.144.97
- IP address: 172.64.144.97
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
